Skip to main content
. 2006 Sep;3(9):43–55.

Table 4.

Guidelines on how to select a mood-stabilizing medication for bipolar disorder

Indication Lithium Carbamazepine oxcarbazepine Valproate Lamotrigine Risperidone Olanzapine Quetiapine Ziprasidone Aripiprazole
Mania
  • FDA approval

  • Euphoric

  • Irrit./Mixed

  • +

  • +

  • ?

  • ±

  • +

  • +?

  • +

  • +

  • +

  • -

  • ?

  • ?

  • +

  • +

  • ?

  • +

  • +

  • +

  • +

  • +

  • ?

  • +

  • +

  • +

  • +

  • +

  • ?

Rapid cycling ± +? + + ? + ? ? ?
Use in hepatic disease + ± ? + + +(1) + + +
Use in renal disease - + + + - + + + +
Use in rash patients + ± + ? + + + + +
Medical-induced mania - + + ? +? + ? + +
Violence/rapid stabilization ?+ ?+ + - +? + ? + ?
Substance comorbidity - + + ? ? + ? ? ?
Long-term depression + ? ? + ? +(2) ? ? ?
FDA Class D D/C D C C C C C C
Breastfeeding - + + - - - - - -
Hormone effects - Ind. OC(3) ? - Prolactin - - - -
Short-term side effects Cognition Polydip. Tremor Sedation Anemia LFT elev. Sedation Weight gain LFT elev. Rash Headache Wt. gain EPS(4) Gluc. elev.(5) Weight gain Sedation Gluc. elev Gluc. elev Agitation Sedation Agitation
Long-term side effects Thyroid Renal Anemia Pan's? PCO - T.D.? Chol. elev. T.D.? Chol. elev. T.D.? Chol. elev. T.D.? T.D.?
Dosing 600-2400 (0.6–1.2) QD or BID 400–1200/ 600–1800 BID 750–2500(6) (50–125) BID 100mg BID 2–6mg BID 5–20mg HS 300–600mg BID 40–80mg BID 10–30mg AM

Notes: Evidence base—haloperidol and thioridizine also FDA-approved for mania, but not commonly used.

(1)

Olanzapine—Rare reports of LFT elevation

(2)

Option to use combined form (olanzapine/fluoxetine = Symbyax).

(3)

Induction of oral contraceptives—carbamazepine oxcarbazepine and topiramate.

(4)

Risperdone—EPS = extrapyramidal side effects and TD = tardive dyskinesia.

(5)

Glucose and cholesterol elevation—may be more for olanzapine, risperidone, and quetiapine than for ziprasidone and aripiprazole.

(6)

Valproate ER dosed 500–3000mg HS.